Filing Details

Accession Number:
0000950170-24-018785
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-22 16:18:22
Reporting Period:
2024-02-20
Accepted Time:
2024-02-22 16:18:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1754068 Allovir Inc. ALVR Biological Products, (No Disgnostic Substances) (2836) 831971007
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1818070 Diana Brainard C/O Allovir, Inc.
1100 Winter Street
Waltham MA 02451
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-02-20 3,097 $0.70 819,224 No 4 S Direct
Common Stock Disposition 2024-02-21 5,155 $0.71 814,069 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.6832 to $0.7150. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.7002 to $0.7098. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.